title: Correlates between hyperinsulinism and hyperandrogenemia?
authors.forename: Eva N
authors.initials: EN
authors.lastname: Kassi
authors.forename: Evanthia
authors.initials: E
authors.lastname: Diamanti-Kandarakis
authors.forename: Athanasios G
authors.initials: AG
authors.lastname: Papavassiliou
mesh_terms: D015067:17-Hydroxysteroid Dehydrogenases / Q000235:genetics / Q000378:metabolism; D015096:3-Hydroxysteroid Dehydrogenases; D000255:Adenosine Triphosphate / Q000378:metabolism; D000074425:Aldo-Keto Reductase Family 1 Member C3; D000735:Androstenedione / Q000097:blood; D022782:CCAAT-Enhancer-Binding Protein-beta / Q000378:metabolism; D003981:Diazoxide / Q000627:therapeutic use*; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D006911:Hydroxyprostaglandin Dehydrogenases; D017588:Hyperandrogenism / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D006946:Hyperinsulinism / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D007328:Insulin / Q000097:blood; D016729:Leuprolide / Q000627:therapeutic use*; D011085:Polycystic Ovary Syndrome / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D013739:Testosterone / Q000097:blood; D013851:Thinness
chemical_list: D022782:CCAAT-Enhancer-Binding Protein-beta; D007328:Insulin; D013739:Testosterone; D000735:Androstenedione; D000255:Adenosine Triphosphate; D015067:17-Hydroxysteroid Dehydrogenases; D015096:3-Hydroxysteroid Dehydrogenases; D006911:Hydroxyprostaglandin Dehydrogenases; C487341:AKR1C3 protein, human; D000074425:Aldo-Keto Reductase Family 1 Member C3; D016729:Leuprolide; D003981:Diazoxide